Replies to post #801 on Cytodyn Inc (CYDY)

[misiu143]

I don't like this article. I think it is unfair
to CytoDyn.
It doesn't stress enough the important things.

-- More serious side effects, in the studies with long acting therapy. About 6% patients dropped because of that.

-- He said that with Pro 140, 14% patients developed Diarrhea , and 14 % developed headache , I can't find that , I see this with long acting therapy , but can't find with Pro 140.

--Possibility of developing RESISTANT with long acting therapy much higher than with Pro 140 .So far no resistant with Pro 140.
And we see patients developed resistant with long acting therapy.

--Toxicity stay much longer with long acting therapy.

--going to clinic every 4-8 wks for im injection , is imo much
more difficult and painful ,than self sc injections every week.
( some diabetic patients inject insulin sc couple times a day)

-- I think they putting Charlie S on Phase 2 , so they can start treatment asap.

All together I think it was a bias article against CytoDyn, but this is a small company , without big money behind .In a way I am not surprise .

[chumppunk]

Amatuer17-you mentioned peer reviewed. Biotech protocol isn't my area. I do remember maybe on the Yahoo board this being brought up and covered. As for me Pro-140 isn't being independently company trailed but by multiple different locations all coming up with the same results. That's a plus to me.
Chump